Developing Therapeutics That Teach the Body to Heal Itself
American Gene™ Plans for Phase 2 Trial of AGT103-T American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints... [Read More]...
Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus... [Read More]...
Dr. Wells’ promotion comes as the company’s HIV clinical trial progresses American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head... [Read More]...
Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point... [Read More]...
Clinical Trial Progress Update The analytic treatment interruption (ATI) protocol is generating important immunological data. We are currently gathering and analyzing data from five out of the seven clinical... [Read More]
Exciting HIV Clinical Trial Update American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals. “This is a critical step in our mission to cure HIV... [Read More]...
HIV Program Treatment Withdrawal Safety and efficacy blood markers have been recorded in the Phase 1 human trial for AGT’s HIV cure. We expect the antiretroviral treatment withdrawal studies to... [Read More]
HIV Program Update Five for Five! American Gene Technologies (AGT) announced that it has reached another important milestone in its HIV cure program. Five participants were treated with AGT103-T and... [Read More]
Subscribe to our YouTube Channel Dr. Conant was the first physician to diagnose HIV in San Francisco while running the inpatient dermatology service at the University of California San Francisco.... [Read More]
Subscribe to our YouTube Channel On the heels of Silicon Valley’s branding as one of the world’s largest tech hubs, the BioHealth Capital Region aims to brand the DMV region... [Read More]
Subscribe to our YouTube Channel Mantell Associates Network interviews Jeff Galvin, CEO and Founder of American Gene Technologies™ (AGT) for its global Podcast listeners. In this interview, Galvin shares the... [Read More]
Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies, presents AGT’s latest news at the BIO Digital International Convention 2021. As the first patient in AGT’s Phase... [Read More]
Original post on Poz.com By Trent Straube Sexual molestation as a child, an abusive father, the foster care system, violent street gangs, an HIV diagnosis as a teenager. “Anything you can think... [Read More]
The Biotech Project podcast welcomes CEO and Founder of American Gene Technologies®, Jeff Galvin, onto the show to discuss the past, present, and future of the company’s mission to use... [Read More]
Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview to learn how gene therapy works, and what... [Read More]
Have a listen. From Lab to Launch by Qualio Jeff is the CEO and founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard and has... [Read More]
The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder and CEO Jeff Galvin for a lively and... [Read More]
In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror of the Russia-Ukraine war and rampant inflation, which has led many to a state... [Read More]
American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient’s own T cells which have been enhanced for HIV resistance, and... [Read More]
Gene Therapy Does It “My Way” In 1990, gene therapy burst onto the world stage with the first clinical trial aimed at a genetic disease. This effort, led by a... [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
